Stock Updates

Today’s Top Gainers in the Market Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) from Healthcare

Today’s top gainers include the company Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) which is in the industry Biotechnology, gaining -0.60% today. In the last week its performance is -2.44%, and -9.93% for the past quarter. Currently, Alexion Pharmaceuticals, Inc., ALXN has a target price of 171.75, so today’s gain of -0.60% is a significant step towards its target price. The GAP today is therefore -0.20%.

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), has a market cap of 28495.5, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 98.30%.

At the current price of 125.09, it has a dividend yield of *TBA, and its target price is 171.75. This is with a profit margin of 3.20%, and total debt/equity of 0.4. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has a P/E of 316.68, as well as a forward P/E of 20.92.

With a current EPS of 0.4, and a forecasted EPS growth for next year at 28.64%,Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has had a EPS growth for the past five years at 5.10%. For the next five years EPS growth is projected to be 18.28%.

Performance for the year is -29.30%. Since its IPO date on 2/28/1996, the total performance to date is -34.42%.

Volume today for Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), is 915400, while its average volume is 1903.74. Whilst the total gain today was -0.60%, it did have a day high of -9.62%.

Volatility for this week has been at 2.46%, and 2.22% for the month. The 52-week low for Alexion Pharmaceuticals, Inc., ALXN has been 13.14%, while the 52-week-high has reached -35.34%.

Looking at its return of investments, which is 1.60%, and its return on assets is 0.70%. Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has an operating margin of 21.70%. With a sales growth of 18.40% quarter over quarter. Bearing in mind that Alexion Pharmaceuticals, Inc., ALXN is in the sector Healthcare, its long-term debt/equity is 0.39, and has a current ratio of 3.6 and 3.1 for quick ratio.

So what is the value of Alexion Pharmaceuticals, Inc.? Well its PEG is 17.32, and the P/S is 10.1, along with a P/B of 3.42. Meanwhile it has a p/cash of 24.15.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Mark Hines

Leave a Comment